METABOLIC SYNDROME AND OBESITY ACCORDING TO IFD/LAAD CRITERIA IN ADULTS IN THE CITY OF SALTA
DOI:
https://doi.org/10.31052/1853.1180.v22.n2.18630Keywords:
Metabolic síndrome, Obesity, adultsAbstract
Abstract:
Objective: To estimate the prevalence of Metabolic Syndrome in adults in Salta according to criteria from International Federation of Diabetes (IFD) and Latin American Association of Diabetes (LAAD). Analyze the relationship between obesity and Metabolic Syndrome. Methodology: cross-sectional study, secondary data base (Nutritional Survey, Salta. 2014) Variables: MS: criteria IFD/LAAD, sex, age, nutritional status. Analysis: frequency distribution, comparison of measures. Logistic regression. EXCEL, SPSS 18. Results: We evaluated 425 adults; 63.5 % women. The prevalence of MS was 20.9% according to LAAS, 30.8% according to IFD, greater in males (34.2 and 41.9%). The prevalence of Overweight/Obesity was 61.8%. The mean values of BMI, triglycerides and blood pressure in males were higher than the critical limits. Regression models (IFD/LAAD) showed that the probability to develop MS was greater in males, increased with age (?65 years) and with overweight/obesity. Conclusions: we observed differences in the prevalence of MS according to the medical diagnosis used, being associated with overweight/obesity.
Downloads
References
1.García-García E, De la Llata-Romero M, Kaufer-Horwitz M, Tusié-Luna MT, Calzada-León R, Vázquez-Velázquez et al . La obesidad y el síndrome metabólico como problema de salud pública: una reflexión. Salud pública Méx [Internet]. 2008 Dec [cited 2017 Mar 31] ; 50( 6 ): 530-547. Available from: http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36342008000600015&lng=en. http://dx.doi.org/10.1590/S0036-36342008000600015
2. Tercer Encuesta Nacional de Factores de Riesgo. http://www.msal.gob.ar/images/stories/bes/graficos/0000000544cnt-2015_09_04_encuesta_nacional_factores_riesgo.pdf
3. Rosas Guzmán J., González Chávez A., Aschner P., Bastarrachea R. y col. Epidemiología, Diagnóstico, Control, Prevención y Tratamiento del Síndrome Metabólico en Adultos. Consensos ALAD. 2010. Vol. XVIII. Nº 1.
4. The IDF consensus worldwide definition of the metabolic syndrome. https://www.pitt.edu/~super1/Metabolic/IDF1.pdf
5. BMI Classification. Disponible en: www.apps.who.int/bmi/index jsp
6. Barrera MP, Pinilla AE, Cortés E, Mora G, Rodríguez MN. Síndrome metabólico: una mirada interdisciplinaria. Rev Colomb Cardiol. 2008.Vol15(3):111-26.
7. Vicario A, Cerezo GH, Zilberman J, Del Sueldo M. Prevalencia del síndrome metabólico en la consulta cardiológica y utilidad de la percepción médica como herramienta diagnóstica. Estudio CARISMA (Caracterización y Análisis del Riesgo en Individuos con Síndrome Metabólico en la Argentina). Rev Fed Arg Cardiol [Internet]. 2011 [citado 10 Nov 2011];40(2):152-7. Disponible en: http://www.fac.org.ar/1/revista/11v40n2/art_orig/arorig03/vicario.pdf
8. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120:1640-45.
9. Benozzi S, Ordoñez F, Polini N, et al: Insulino resistencia y síndrome metabólico en pacientes con enfermedad coronaria definida por angiografía. MEDICINA (Buenos Aires) 2009;69: 221-28.
10. Luquez H, De Loredo L, Madoery RJ, Luquez H (h),Senestrari D. Síndrome metabólico: prevalencia en dos comunidades de Córdoba, Argentina, de acuerdo con definiciones ATP-III y OMS. Rev Fed Arg Cardiol 2005; 34: 80-95.
11. Luquez HA. Síndrome metabólico. Las definiciones actuales y la realidad Argentina. Rev Fed Arg Cardiol 2005;34:195-201.
12. Coniglio RI, Nellem J, Gentili R, et al. Estudio IFRALAC 2009: Síndrome metabólico en empleados en la Argentina. MEDICINA (Buenos Aires)2009; 69: 246-52.
13. Schargrodsky H, Hernández R, Marcet-Champagne B, et al. CARMELA Study. Am J Med 2008; 121:53-55.
14. Pramparo P, Boissonnet C, Schargrodsky H. Evaluación del riesgo cardiovascular en siete ciudades de Latinoamérica: las principales conclusiones del estudio CARMELA y de los subestudios. Rev. argent. cardiol. [Internet]. 2011 Ago [citado 2017 Mar 30] ; 79( 4 ): 377-382. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S1850-37482011000400014&lng=es
15. Ortiz-Benavidesb R, Sigüenza-Cruzc W, Ortiz-Benavidesd A, A˜ neze R, Salazare J, Rojase J y Bermúdeze V .Punto de corte de circunferencia abdominal para el agrupamiento de factores de riesgo metabólico: una propuesta para la población adulta de Cuenca, Ecuador. Rev argent endocrinol metab2016; 53(2):59–66.
16. Bustillo Solano E, Pérez Francisco Y, Brito García A, González Iglesia A, Castañeda Montano D, Santos González M et al . Síndrome metabólico, un problema de salud no diagnosticado. Rev Cubana Endocrinol [Internet]. 2011 Dic [citado 2017 Abr 03] ; 22( 3 ): 167-181. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532011000300001&lng=es.
17. Obesidad. Nota descriptiva N°311.Junio de 2016 http://www.who.int/features/factfiles/obesity/es/
18. Tercera Encuesta Nacional de Factores de Riesgo http://www.msal.gob.ar/images/stories/bes/graficos/0000000544cnt 2015_09_04_encuesta_nacional_factores_riesgo.pdf.
19.Lizarzaburu Robles JC .Síndrome metabólico: concepto y aplicación práctica. An Fac Med 2013; 74(4):315-20.
20. Ezquerra EA, Castellano Vázquez JM, Barrero AA. Obesidad, síndrome metabólico y diabetes: implicaciones cardiovasculares y actuación terapéutica. Rev Esp Cardiol 2008; 61(7):752-64.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Escuela de Salud Pública y Ambiente. Facultad de Ciencias Médicas. Universidad Nacional de Córdoba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License which allows the work to be copied, distributed, exhibited and interpreted as long as it is not done for commercial purposes.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) after the publication process. (See The Effect of Open Access). (See The Effect of Open Access).
How to Cite
